LataMed AI is trading 6.3% lower at $0.07, with no clear company-specific catalyst identified for the decline.
- No September 28 company-specific announcement surfaced.
- The latest identified company news was a September 9 cooperation agreement for a planned healthcare technology deployment in La Guaira.
- U.S. stocks fell amid rising oil prices after President Trump rejected Iran’s proposal, while higher Treasury yields revived inflation concerns. A direct link to LataMed AI’s move has not been established.